title: Tumor necrosis factor alpha is released by monocytes in OKT3 monoclonal antibody immunosuppressive therapy.
authors: Laboratory of Immunology, Hospital Alarcos, Ciudad Real, Oviedo, Spain.
authors: J M
authors: JM
authors: Urra
authors: R
authors: R
authors: Peces
authors: E
authors: E
authors: Martinez-Naves
authors: V
authors: V
authors: Gutierrez
authors: F
authors: F
authors: Setién
authors: C
authors: C
authors: López-Larrea
mesh_terms: D002460:Cell Line; D002478:Cells, Cultured; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D005434:Flow Cytometry; D006801:Humans; D008264:Macrophages / Q000187:drug effects / Q000276:immunology; D009000:Monocytes / Q000187:drug effects* / Q000276:immunology; D016853:Muromonab-CD3 / Q000494:pharmacology*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
chemical_list: D016853:Muromonab-CD3; D014409:Tumor Necrosis Factor-alpha